MedSci Healthcare Holdings Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. The Group is expected to record a profit attributable to the Shareholders of approximately around RMB 10 million for the six months ended 30 June 2023 as compared to a net loss attributable to the Shareholders recorded for the six months ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 HKD | +1.10% | -3.50% | -42.14% |
04-26 | Certain Shares of MedSci Healthcare Holdings Limited are subject to a Lock-Up Agreement Ending on 26-APR-2024. | CI |
04-01 | Medsci Healthcare Rebounds to 2023 Profit | MT |
1st Jan change | Capi. | |
---|---|---|
-42.14% | 187M | |
-24.93% | 2.77B | |
-51.47% | 2.5B | |
-1.73% | 223M | |
-53.14% | 202M | |
-33.52% | 109M |
- Stock Market
- Equities
- 2415 Stock
- News MedSci Healthcare Holdings Limited
- MedSci Healthcare Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023